Expired European patentEurope
Prescreening of prostate cancer by serum prostatic specific antigen
EP 0579607 B1 · Applicant: ENDORECHERCHE INC.
Overview
The published document from the EPO: abstract, claims, description and drawings. Open it full size
Read the whole patent
Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 13, 1992 and granted March 13, 1996. A European patent lasts at most 20 years from filing, so its term ended January 13, 2012.
- A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by July 13, 2017.
- We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledJanuary 13, 1992
PublishedJanuary 26, 1994
GrantedMarch 13, 1996
Term endedJanuary 13, 2012
Application numberEP 92902434
Classification (CPC)G01N33/57525
Timeline
Timeline From EPO dates
Sources & verification
Official EPO records
Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.